Etanercept
Use attributes for filter ! | |
Formula | C2224H3475N621O698S36 |
---|---|
Molar mass | 51234. 9 g/mol g·mol−1 |
Other names | etanercept-szzs, etanercept-ykro |
Trade name | Enbrel, Benepali |
Elimination half-life | 70–132 hours |
Metabolism | Reticuloendothelial |
Music groups | Adalimumab |
Infliximab | |
Methotrexate | |
Date of Reg. | |
Date of Upd. | |
ID | 2951166 |
About Etanercept
Etanercept, sold under the brand name Enbrel among others, is a biopharmaceutical that treats autoimmune diseases by interfering with tumor necrosis factor by acting as a TNF inhibitor.